Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05052190 · ClinicalTrials.gov registry record · NA
Patient Portal Flu Vaccine Reminders_RCT 4
A NA study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 239,567
- Enrollment target
NCT05052190 is a NA study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 239,567 participants.
The verdict
NCT05052190, a NA study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 239,567 participants
- Enrollment target
Study Summary
This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. The study design is a 2x2 nested factorial design. Patients will be randomized into 1) receiving text based reminder messages, 2) portal-based reminder messages or 3) the control group. Patients randomized to the intervention arms will receive reminders if they are due for influenza vaccine. Nested within the reminder arms (text or portal), we will have 2 additional components for which patients will be randomized separately: * A direct scheduling link within the reminder letter enabling the patient to schedule an influenza vaccine only visit (direct scheduling link vs. no direct scheduling link). * A pre-appointment reminder, encouraging patients to ask for their influenza vaccine at their upcoming appointment (pre-appointment reminder encouraging influenza vaccination vs. standard pre-appointment reminder not mentioning influenza vaccination) Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low: at 6m-4.9 yrs. (70%), 5-17.9 yrs. (56%), 18-64.9 yrs. (38%), and \>65 yrs. (63%). The investigators will assess the effectiveness of MyChart R/R messages and text R/R messages as compared to the standard of care control (no messages).
Interventions
- BEHAVIORAL Text Pre-Appointment Reminder
- BEHAVIORAL Text Message R/R with Direct Appointment Schedule Link
- BEHAVIORAL Text Message R/R without Direct Appointment Schedule Link
- BEHAVIORAL Portal Message R/R with Direct Appointment Schedule Link
- BEHAVIORAL Portal Message R/R without Direct Appointment Schedule Link
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239,567 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2022-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05052190
The ClinicalTrials.gov registry entry for NCT05052190 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 239,567 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Text Pre-Appointment Reminder is the first listed.
NCT05052190 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05052190 about?
NCT05052190 is a clinical study titled "Patient Portal Flu Vaccine Reminders_RCT 4". This trial is taking place in Los Angeles, CA at clinics within the UCLA Health System. The study design is a 2x2 nested factorial design. Patients will be randomized into 1) receiving text based reminder messages, 2) portal-based reminder messages or 3) the control group. Patients randomized to th...
What is the current status of trial NCT05052190?
This trial is currently terminated. It is a NA study. The enrollment target is 239,567 participants. The study started on 2021-10-14. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT05052190?
The interventions under investigation include: Text Pre-Appointment Reminder (BEHAVIORAL), Text Message R/R with Direct Appointment Schedule Link (BEHAVIORAL), Text Message R/R without Direct Appointment Schedule Link (BEHAVIORAL), Portal Message R/R with Direct Appointment Schedule Link (BEHAVIORAL), Portal Message R/R without Direct Appointment Schedule Link (BEHAVIORAL).
Who is sponsoring clinical trial NCT05052190?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.